Patents by Inventor Christian P. Behrenbruch

Christian P. Behrenbruch has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antigen binding constructs to CD3
    Patent number: 10882909
    Abstract: Antigen binding constructs that bind to CD3, for example antibodies, including antibody fragments (such as minibodies and cys-diabodies) that bind to CD3, are described herein. Methods of use are described herein.
    Type: Grant
    Filed: April 25, 2019
    Date of Patent: January 5, 2021
    Assignee: ImaginAb, Inc.
    Inventors: David T. Ho, Tove Olafsen, Jason Romero, Christian P. Behrenbruch
  • ANTIGEN BINDING CONSTRUCTS TO CD8
    Publication number: 20200140550
    Abstract: Antigen binding constructs that bind to CD8, for example antibodies, including antibody fragments (such as scFv, minibodies, and cys-diabodies) that bind to CD8, are described herein. Methods of use are described herein.
    Type: Application
    Filed: January 16, 2020
    Publication date: May 7, 2020
    Inventors: David T. Ho, Tove Olafsen, Giti Agahi, Christian P. Behrenbruch
  • ANTIGEN BINDING CONSTRUCTS TO CD8
    Publication number: 20190382487
    Abstract: Antigen binding constructs that bind to CD8, for example antibodies, including antibody fragments (such as scFv, minibodies, and cys-diabodies) that bind to CD8, are described herein. Methods of use are described herein.
    Type: Application
    Filed: May 20, 2019
    Publication date: December 19, 2019
    Inventors: David T. Ho, Tove Olafsen, Giti Agahi, Christian P. Behrenbruch
  • ANTIGEN BINDING CONSTRUCTS TO CD8
    Publication number: 20190382488
    Abstract: Antigen binding constructs that bind to CD8, for example antibodies, including antibody fragments (such as scFv, minibodies, and cys-diabodies) that bind to CD8, are described herein. Methods of use are described herein.
    Type: Application
    Filed: May 20, 2019
    Publication date: December 19, 2019
    Inventors: David T. Ho, Tove Olafsen, Giti Agahi, Christian P. Behrenbruch
  • ANTIGEN BINDING CONSTRUCTS TO CD3
    Publication number: 20190309068
    Abstract: Antigen binding constructs that bind to CD3, for example antibodies, including antibody fragments (such as minibodies and cys-diabodies) that bind to CD3, are described herein. Methods of use are described herein.
    Type: Application
    Filed: April 25, 2019
    Publication date: October 10, 2019
    Inventors: David T. Ho, Tove Olafsen, Jason Romero, Christian P. Behrenbruch
  • Antigen binding constructs to CD8
    Patent number: 10414820
    Abstract: Antigen binding constructs that bind to CD8, for example antibodies, including antibody fragments (such as scFv, minibodies, and cys-diabodies) that bind to CD8, are described herein. Methods of use are described herein.
    Type: Grant
    Filed: March 10, 2014
    Date of Patent: September 17, 2019
    Assignee: IMAGINAB, INC.
    Inventors: David T. Ho, Tove Olafsen, Giti Agahi, Christian P. Behrenbruch
  • Antigen binding constructs to CD8
    Patent number: 10377826
    Abstract: Antigen binding constructs that bind to CD8, for example antibodies, including antibody fragments (such as scFv, minibodies, and cys-diabodies) that bind to CD8, are described herein. Methods of use are described herein.
    Type: Grant
    Filed: August 5, 2016
    Date of Patent: August 13, 2019
    Assignee: IMAGINAB, INC.
    Inventors: David T. Ho, Tove Olafsen, Giti Agahi, Christian P. Behrenbruch
  • Antigen binding constructs to CD3
    Patent number: 10301389
    Abstract: Antigen binding constructs that bind to CD3, for example antibodies, including antibody fragments (such as minibodies and cys-diabodies) that bind to CD3, are described herein. Methods of use are described herein.
    Type: Grant
    Filed: June 13, 2013
    Date of Patent: May 28, 2019
    Assignee: IMAGINAB, INC.
    Inventors: David T. Ho, Tove Olafsen, Jason Romero, Christian P. Behrenbruch
  • Antigen binding constructs to CD8
    Patent number: 10072080
    Abstract: Antigen binding constructs that bind to CD8, for example antibodies, including antibody fragments (such as scFv, minibodies, and cys-diabodies) that bind to CD8, are described herein. Methods of use are described herein.
    Type: Grant
    Filed: August 5, 2016
    Date of Patent: September 11, 2018
    Assignee: ImaginAB, Inc.
    Inventors: David T. Ho, Tove Olafsen, Giti Agahi, Christian P. Behrenbruch
  • ANTIGEN BINDING CONSTRUCTS TO CD8
    Publication number: 20170029507
    Abstract: Antigen binding constructs that bind to CD8, for example antibodies, including antibody fragments (such as scFv, minibodies, and cys-diabodies) that bind to CD8, are described herein. Methods of use are described herein.
    Type: Application
    Filed: August 5, 2016
    Publication date: February 2, 2017
    Inventors: David T. Ho, Tove Olafsen, Giti Agahi, Christian P. Behrenbruch
  • ANTIGEN BINDING CONSTRUCTS TO CD8
    Publication number: 20160024209
    Abstract: Antigen binding constructs that bind to CD8, for example antibodies, including antibody fragments (such as scFv, minibodies, and cys-diabodies) that bind to CD8, are described herein. Methods of use are described herein.
    Type: Application
    Filed: March 10, 2014
    Publication date: January 28, 2016
    Inventors: David T. Ho, Tove Olafsen, Giti Agahi, Christian P. Behrenbruch
  • ANTIGEN BINDING CONSTRUCTS TO CD3
    Publication number: 20150118252
    Abstract: Antigen binding constructs that bind to CD3, for example antibodies, including antibody fragments (such as minibodies and cys-diabodies) that bind to CD3, are described herein. Methods of use are described herein.
    Type: Application
    Filed: June 13, 2013
    Publication date: April 30, 2015
    Inventors: David T. Ho, Tove Olafsen, Jason Romero, Christian P. Behrenbruch
  • ANTIGEN BINDING CONSTRUCTS TO CD8
    Publication number: 20140271462
    Abstract: Antigen binding constructs that bind to CD8, for example antibodies, including antibody fragments (such as scFv, minibodies, and cys-diabodies) that bind to CD8, are described herein. Methods of use are described herein.
    Type: Application
    Filed: March 10, 2014
    Publication date: September 18, 2014
    Applicant: IMAGINAB, INC.
    Inventors: David T. Ho, Tove Olafsen, Giti Agahi, Christian P. Behrenbruch